Oramed Pharmaceuticals ORMP Q4 2025 Earnings Positive EPS Surprise Amid Revenue Void Stock Slips ATLC Q1 2026 Earnings EPS Surges 2579 Above Estimates AVXL Q1 2026 Earnings NarrowerThanExpected Loss Fails to Lift Shares CNL Q1 2026 Earnings WiderThanExpected Loss as PreRevenue Exploration Continues Soligenix SNGX Q1 2026 Earnings Narrowed Loss Per Share Offers a Modest Surprise Despite No Revenue GPRE Q1 2026 Earnings Massive EPS Beat Driven by Operational Improvements Portillos Inc PTLO Q1 2026 Earnings Narrowing Losses but EPS Misses Street on Thin Margin AFGD Q1 2026 Earnings EPS Misses Estimates Subordinated Debentures Edge Higher BRSP Q1 2026 Earnings EPS Misses Estimates as Commercial Real Estate Headwinds Persist